Skip to main content
CriticalFDAfda-F-1049-2013LISTERIA

Cold Smoke Atlantic Salmon Nordic Choice Pre-sliced Vacuum Packed

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
3,425
Recall Date
December 18, 2012
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2013.

Results from the company lab samples revealed that some of the samples contained Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Mkg Provisions Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2013.

Mkg Provisions Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Mkg Provisions Inc Recall FAQ

Mkg Provisions Inc is the subject of a seafood safety report: Cold Smoke Atlantic Salmon Nordic Choice Pre-sliced Vacuum Packed. The notice was published on December 18, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 3,425 units are potentially affected.